Mannitol Administration for Delerium Prevention

NCT06759259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-12-09

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of adjuvant administration of mannitol for the prevention of delirium in patients with myocardial infarction.

Conditions

  • Myocardial Infarction (MI)
  • Delirium, Intensive Care Unit, Randomised Controlled Trial

Sponsors & Collaborators

  • Tomsk National Research Medical Center of the Russian Academy of Sciences

    lead OTHER

Principal Investigators

  • Oleg Panteleev, MD · Tomsk NRMC

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-29
Primary Completion
2025-02-01
Completion
2025-10-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06759259 on ClinicalTrials.gov